Navitor Pharmaceuticals, Inc.

As 2022 draws to a close, an unusually low number of marquee deals have been made in the biopharma sector. But it has been a hectic year nonetheless, with a high volume of deal-making and the lower va

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Amgen, Plexium Team Up Against Challeng

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . Novartis Pays $30m To Partne

Leading immuno-oncology pioneer, Daniel Chen , has been appointed chief medical officer, a newly created position, at Mountain View, CA-based IGM Biosciences , to lead its clinical development act